DK2200585T3 - Anvendelse af deuteriumoxid til behandling af virusbaserede hudsygdomme - Google Patents

Anvendelse af deuteriumoxid til behandling af virusbaserede hudsygdomme

Info

Publication number
DK2200585T3
DK2200585T3 DK08784291.0T DK08784291T DK2200585T3 DK 2200585 T3 DK2200585 T3 DK 2200585T3 DK 08784291 T DK08784291 T DK 08784291T DK 2200585 T3 DK2200585 T3 DK 2200585T3
Authority
DK
Denmark
Prior art keywords
treatment
skin diseases
deuterium oxide
viral skin
viral
Prior art date
Application number
DK08784291.0T
Other languages
English (en)
Inventor
Thomas Bayerl
Original Assignee
D2 Bioscience Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by D2 Bioscience Group Ltd filed Critical D2 Bioscience Group Ltd
Application granted granted Critical
Publication of DK2200585T3 publication Critical patent/DK2200585T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK08784291.0T 2007-07-05 2008-07-03 Anvendelse af deuteriumoxid til behandling af virusbaserede hudsygdomme DK2200585T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007031397A DE102007031397A1 (de) 2007-07-05 2007-07-05 Verwendung von Deuteriumoxid zur Behandlung von Virus-basierten Erkrankungen der Haut
PCT/DE2008/001103 WO2009003463A2 (de) 2007-07-05 2008-07-03 Verwendung von deuteriumoxid zur behandlung von virus-basierten erkrankungen der haut

Publications (1)

Publication Number Publication Date
DK2200585T3 true DK2200585T3 (da) 2014-06-16

Family

ID=39846629

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08784291.0T DK2200585T3 (da) 2007-07-05 2008-07-03 Anvendelse af deuteriumoxid til behandling af virusbaserede hudsygdomme

Country Status (5)

Country Link
US (1) US8609147B2 (da)
EP (2) EP2452676A1 (da)
DE (1) DE102007031397A1 (da)
DK (1) DK2200585T3 (da)
WO (1) WO2009003463A2 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2110132T3 (da) * 2008-04-20 2014-04-28 D2 Bioscience Group Ltd Anvendelse af deuteriumoxid som elastasehæmmer
DE102009003992A1 (de) * 2009-01-07 2010-07-08 D2O Biosience Group Ltd., Hamilton Verwendung von Deuteriumoxid zur Behandlung Virus-basierter Erkrankungen des Respirationstraktes
DE102009003942A1 (de) * 2009-01-07 2010-07-08 D2O Biosience Group Ltd., Hamilton Verwendung von Deuteriumoxid zur Behandlung Virus-basierter Erkrankungen des Auges

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3019434A1 (de) * 1980-05-21 1982-01-28 Horst Hanschmann Verfahren zur entkeimung von lebenden zellen
US5028431A (en) * 1987-10-29 1991-07-02 Hercon Laboratories Corporation Article for the delivery to animal tissue of a pharmacologically active agent
US5223269A (en) * 1989-08-31 1993-06-29 Andrejs Liepins Methods and composition for the treatment of hypertension
US5233269A (en) * 1990-04-13 1993-08-03 Varian Associates, Inc. Vacuum tube with an electron beam that is current and velocity-modulated
DE4343838C2 (de) * 1993-12-22 1998-07-09 Lohmann Therapie Syst Lts Deuteriertes Arzneimittel in transdermaler Applikation und Verfahren zu seiner Herstellung
HU214593B (hu) * 1994-03-23 1998-06-29 HYD Kutató-Fejlesztő Kft. Kozmetikai, higiéniai, valamint szépség- és testápoló készítmények és eljárás azok előállítására
DE4427690A1 (de) 1994-08-04 1996-02-08 Bogdahn Ulrich Prof Deuterium enthaltende pharmazeutische Zusammensetzung als Zytostatikum oder Tumor-Therapeutikum
US6009876A (en) * 1997-05-20 2000-01-04 Yavitz; Edward Q. Method for modifying and reshaping collagen beneath the surface of skin
RU2083210C1 (ru) * 1995-09-13 1997-07-10 Николаева Ирина Сергеевна Средство для профилактической, поддерживающей и восстановительной терапии развивающихся при старении и/или под воздействием патогенных факторов патологий, связанных с дистрофическим и дегенеративными изменениями органов и тканей
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
US20030157187A1 (en) * 1996-12-02 2003-08-21 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory diseases
US6495579B1 (en) * 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US20070129282A1 (en) * 1998-11-24 2007-06-07 Ahlem Clarence N Pharmaceutical treatments and compositions
US6958390B1 (en) * 2000-06-14 2005-10-25 Stratagene California Compositions and kits for herpes simplex virus type 1 and 2 nucleic acid detection
US20040086453A1 (en) * 2001-01-22 2004-05-06 Howes Randolph M. Compositions, methods, apparatuses, and systems for singlet oxygen delivery
WO2004026313A1 (en) * 2002-09-17 2004-04-01 Nippon Boehringer Ingelheim Co., Ltd. Pharmaceutical composition for topical delivery of meloxicam comprising an amine or amine as penetration enhancer.
US7132452B2 (en) * 2003-03-10 2006-11-07 Fang-Yu Lee Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection
DE10361944A1 (de) 2003-12-31 2005-07-28 Viromics Gmbh Mittel zur Hemmung der Virusreplikation durch Regulation der Proteinfaltung
US7767215B2 (en) * 2004-06-29 2010-08-03 Mcka Llc Topical compositions for anti-aging and methods of using same
WO2006022460A1 (en) 2004-08-26 2006-03-02 Jong Yoon Bahk Composition and method of use on the deuterium oxide and deuterium oxide related products for prevention, suppression, and treatment of recurrent urothelial cancer and urothelical cancers including bladder cancer
TW200808763A (en) * 2006-05-08 2008-02-16 Astrazeneca Ab Novel compounds I
DE102006026464A1 (de) 2006-06-01 2007-12-06 Virologik Gmbh Innovationszentrum Medizintechnik Und Pharma Pharmazeutische Zusammensetzung zur Behandlung von Virusinfektionen und / oder Tumorerkrankungen durch Inhibition der Proteinfaltung und des Proteinabbaus
DE102006049185A1 (de) * 2006-10-18 2008-04-24 Bayerl, Thomas M., Prof. Dr. Verwendung von Deuteriumdioxid zur Behandlung von hyperproliferativen Erkrankungen der Haut
DK2110132T3 (da) 2008-04-20 2014-04-28 D2 Bioscience Group Ltd Anvendelse af deuteriumoxid som elastasehæmmer
DE102009003942A1 (de) * 2009-01-07 2010-07-08 D2O Biosience Group Ltd., Hamilton Verwendung von Deuteriumoxid zur Behandlung Virus-basierter Erkrankungen des Auges

Also Published As

Publication number Publication date
US8609147B2 (en) 2013-12-17
EP2452676A1 (de) 2012-05-16
US20090011022A1 (en) 2009-01-08
WO2009003463A2 (de) 2009-01-08
DE102007031397A1 (de) 2009-01-08
WO2009003463A3 (de) 2009-08-20
EP2200585A2 (de) 2010-06-30
EP2200585B1 (de) 2014-03-26

Similar Documents

Publication Publication Date Title
DK2504005T3 (da) Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme
DK3456707T3 (da) 4-(p-quinonyl)-2-hydroxybutanamidderivater til behandling af mitokondriesygdomme
DK2480574T3 (da) Anti-cd33-antistoffer og deres anvendelse til immunotargeting i behandlingen af cd33-associerede sygdomme
DK2236149T3 (da) Medicinsk sammensætning til behandling af respiratoriske infektions-sygdomme
DK2056842T3 (da) Modificeret galactosylceramid til behandling af cancerøse sygdomme
DK2222272T3 (da) Behandling af luftvejssygdom
DK2451482T3 (da) Kombinationsterapi til behandlingen af diabetes
DK2919796T3 (da) Brug af akkermansia til behandling af stofskiftesygdomme
DK1937633T3 (da) Biphenyloxyeddikesyrederivater til behandling af respiratoriske sygdomme
CY2014006I1 (el) Μεθοδοι θεραπευτικης αγωγης χρησιμοποιωντας γλυκοπεγκυλιωμενο g-csf
BRPI0908026A2 (pt) Métodos para o tratamento de doenças do intestino
DK3494972T3 (da) Kombinationer af dolutegravir og lamivudin til behandling af HIV-infektion
BRPI0819073A2 (pt) fralda descartável
EP2598149A4 (en) SUBSTITUTED BIPHENYLENE COMPOUNDS AND METHOD FOR USE THEREOF FOR THE TREATMENT OF VIRUS DISEASES
DK1962869T3 (da) Behandling af luftvejssygdomme
DK2285808T3 (da) Spiroindolderivater til behandling af parasitsygdomme
DK2538986T3 (da) Intraartikulært supplement til anvendelse til behandling af ledsygdomme og -skader
BRPI0816712A2 (pt) terapia de intervalo para o tratamento de tinnitus
DK2627345T3 (da) Formuleringer til behandling af sygdomme i de øvre luftveje
DK1940409T3 (da) Nye lægemiddelkombinationer til behandling af åndedrætssygdomme
BRPI0819071A2 (pt) fralda descartável
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme
DK3211005T3 (da) Terapeutisk anvendelse af specifik ligand i msrv-associerede sygdomme
DK2022504T3 (da) Salve til behandling af hæmorider
DK1981515T3 (da) MAPC behandling af hjerneskader og -sygdomme